Loading
EB
Entheon Biomedical Corp. Stock: price and insider trades · Canada
CA·Mcap CA$762.2k
Entheon Biomedical Corp.: what insiders have been doing
Entheon Biomedical Corp. has a thin disclosure history in our data (latest filing: 28 July 2026). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended November 2025 · cache
CA$0.06
Analyst consensus
Income statement
EBITDA-CA$334.2k
Net income-CA$324k0.0% margin
Valuation
PER (trailing)5.5x
P/Book1.6x
Beta1.37
Balance sheet & cash
Market capCA$762.2k
Free Cash Flow-CA$314.7k
Profitability & ownership
ROE9.5%
ROA-41.1%
% insiders4.8%
% institutions0.0%
Last declaration on 28 July 2026
About Entheon Biomedical Corp.
Entheon Biomedical Corp. is a company focused on developing psychedelic treatments for mental health disorders. It is listed on the Toronto Stock Exchange under the symbol XTSE.
